EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

What does “urgency” mean when prioritizing cancer treatment? Results from a qualitative study with German oncologists and other experts during the COVID-19 pandemic

Sabine Sommerlatte, Helene Hense, Stephan Nadolny, Anna-Lena Kraeft, Celine Lugnier, Jochen Schmitt, Olaf Schoffer, Anke Reinacher-Schick, Jan Schildmann

Journal of Cancer Research and Clinical Oncology · 2024

DOI: 10.1007/s00432-024-05863-7 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Sabine Sommerlatte und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for History and Ethics of Medicine, Interdisciplinary Center for Health Sciences, Medical Faculty, Martin Luther University Halle-Wittenber…. Hauptthemen laut MEDLINE: COVID-19, Neoplasms, Oncologists, Qualitative Research. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Martin-Luther-Universität Halle-Wittenberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cancer care in Germany during the COVID-19 pandemic was affected by resource scarcity and the necessity to prioritize medical measures. This study explores ethical criteria for prioritization and their application in cancer practices from the perspective of German oncologists and other experts.

Methods

We conducted fourteen semi-structured interviews with German oncologists between February and July 2021 and fed findings of interviews and additional data on prioritizing cancer care into four structured group discussions, in January and February 2022, with 22 experts from medicine, nursing, law, ethics, health services research and health insurance. Interviews and group discussions were digitally recorded, transcribed verbatim and analyzed using qualitative content analysis.

Results

Narratives of the participants focus on “urgency” as most acceptable criterion for prioritization in cancer care. Patients who are considered curable and those with a high level of suffering, were given a high degree of “urgency.” However, further analysis indicates that the “urgency” criterion needs to be further distinguished according to at least three different dimensions: “urgency” to (1) prevent imminent harm to life, (2) prevent future harm to life and (3) alleviate suffering. In addition, “urgency” is modulated by the “success,” which can be reached by means of an intervention, and the “likelihood” of reaching that success.

Conclusion

Our analysis indicates that while “urgency” is a well-established criterion, its operationalization in the context of oncology is challenging. We argue that combined conceptual and clinical analyses are necessary for a sound application of the “urgency” criterion to prioritization in cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NeoplasmsOncologistsQualitative ResearchHumansGermanyMaleSARS-CoV-2FemaleHealth PrioritiesMedical OncologyMiddle AgedPandemicsAdult

Stichwörter der Autor:innen

Cancer careEmpirical bioethicsPandemicPrioritization criteriaResource allocationUrgency

Autor:innen und Institutionen

  • Institute for History and Ethics of Medicine, Interdisciplinary Center for Health Sciences, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 8, 06112, Halle (Saale), Germany. sabine.sommerlat…
  • Center for Evidence-Based Healthcare, Medical Faculty and University Hospital Carl Gustav Carus , TUD Dresden University of Technology, Dresden, Germany.
  • Institute for History and Ethics of Medicine, Interdisciplinary Center for Health Sciences, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 8, 06112, Halle (Saale), Germany.
  • Institute for Educational and Health-Care Research in the Health Sector, Faculty of Health, Hochschule Bielefeld - University of Applied Sciences and Arts, Interaktion 1, 33619, Bielefeld, Germany.
  • Department of Hematology, Oncology and Palliative Care, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.

Förderung

  • Martin-Luther-Universität Halle-Wittenberg

Zitieren

APA

Sommerlatte, S., Hense, H., Nadolny, S., Kraeft, A. L., Lugnier, C., Schmitt, J., Schoffer, O., Reinacher-Schick, A., & Schildmann, J. (2024). What does “urgency” mean when prioritizing cancer treatment? Results from a qualitative study with German oncologists and other experts during the COVID-19 pandemic. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05863-7

Vancouver

Sommerlatte S, Hense H, Nadolny S, Kraeft AL, Lugnier C, Schmitt J, et al. What does “urgency” mean when prioritizing cancer treatment? Results from a qualitative study with German oncologists and other experts during the COVID-19 pandemic. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05863-7

BibTeX
@article{Sommerlatte2024,
  author = {Sommerlatte, Sabine and Hense, Helene and Nadolny, Stephan and Kraeft, Anna-Lena and Lugnier, Celine and Schmitt, Jochen and Schoffer, Olaf and Reinacher-Schick, Anke and Schildmann, Jan},
  title = {What does “urgency” mean when prioritizing cancer treatment? Results from a qualitative study with German oncologists and other experts during the COVID-19 pandemic},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  doi = {10.1007/s00432-024-05863-7}
}
Kostenlos starten →